- Scrip Originals
Brought to you by
Sequel Pharmaceuticals closes its Series A round
17 Oct 2007
Sequel Pharmaceuticals (cardiovascular therapeutics) has raised $20mm through the sale of Series A preferred stock.
- Venture Financing
Already a Biomedtracker subscriber? You have access to the full deal record through your subscription
Want to become a subscriber? Subscribers get more deal details, updates, deal financials and deal products.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com